This brief activity provides expert insights into the selection of first-line systemic therapy for patients with advanced pancreatic cancer based on best available evidence.
This short activity provides expert insights into selection of second-line systemic therapy for patients with advanced pancreatic cancer.
This brief virtual presentation provides expert insights into the use of PARP inhibitors as maintenance therapy for patients with advanced pancreatic cancer and specific molecular alterations.
This brief virtual presentation provides expert insights into the current optimal use of neoadjuvant and adjuvant therapy strategies for patients with resectable or borderline resectable pancreatic cancer.
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.